HPLC determination and pharmacokinetics study of cefpodoxime in human plasma

徐文炜,夏春华,张红,张会杰,章新晶
2006-01-01
Abstract:Objective:To establish an HPLC method for determination of cefpodoxime to study the pharmacokinetics and bioequivalence of cefpodoxime proxetil in healthy volunteers.Methods:The cefpodoxime was extracted from the plasma with a solid-phase extraction column,and determined by high-performance liquid chromatography at 295 nm.The mobile phase was acetonitrile-sodium acetate (20:80,pH=3.05) with the flow rate of 1.0 mL·min~(-1). The column was Diamonsil ODS(4.6 mm×150 mm,5 μm),the column temperature was 40 ℃.Results:The com- pounds were allowed determination of 0.1-6.4 mg·L~(-1) of cefpodoxime in human plasma with reproducibility(r= 0.9996).The limit of detection was 0.1 mg·L~(-1).Intra-day and inter-day RSD for assaying the plasma sample containing three concentration of cefpodoxime were 2.6%-5.0%and 2.6%-4.3%(n=5),respectively.The mean absolute recovery was 77.06%and the mean relative recovery was 98.68%.Conclusion:The proposed meth- od is simple,sensitive and reproducible.
What problem does this paper attempt to address?